
### [MONDO:0016586](http://purl.obolibrary.org/obo/MONDO_0016586)
**Label:** systemic mastocytosis

**Subclasses:** [MONDO:0015561](http://purl.obolibrary.org/obo/MONDO_0015561) (aleukemic mast cell leukemia), [MONDO:0015560](http://purl.obolibrary.org/obo/MONDO_0015560) (classic mast cell leukemia), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0020332](http://purl.obolibrary.org/obo/MONDO_0020332) (systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease), [MONDO:0020333](http://purl.obolibrary.org/obo/MONDO_0020333) (aggressive systemic mastocytosis), [MONDO:0020334](http://purl.obolibrary.org/obo/MONDO_0020334) (mast cell leukemia), [MONDO:0015558](http://purl.obolibrary.org/obo/MONDO_0015558) (isolated bone marrow mastocytosis), [MONDO:0015557](http://purl.obolibrary.org/obo/MONDO_0015557) (Smouldering systemic mastocytosis), [MONDO:0015559](http://purl.obolibrary.org/obo/MONDO_0015559) (Lymphoadenopathic mastocytosis with eosinophilia), 

**Corr. equiv. classes:** [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:158778](http://www.orpha.net/ORDO/Orphanet_158778), [Orphanet:98849](http://www.orpha.net/ORDO/Orphanet_98849), [Orphanet:158799](http://www.orpha.net/ORDO/Orphanet_158799), [Orphanet:158796](http://www.orpha.net/ORDO/Orphanet_158796), [Orphanet:158775](http://www.orpha.net/ORDO/Orphanet_158775), [Orphanet:98850](http://www.orpha.net/ORDO/Orphanet_98850), [Orphanet:98851](http://www.orpha.net/ORDO/Orphanet_98851), [Orphanet:158793](http://www.orpha.net/ORDO/Orphanet_158793), 

**Class expressions from DL-Learner:**

- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis))) 49.40%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin))) 49.40%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000431](http://purl.obolibrary.org/obo/HP_0000431) (Wide nasal bridge))) 40.69%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000325](http://purl.obolibrary.org/obo/HP_0000325) (Triangular face))) 39.81%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000179](http://purl.obolibrary.org/obo/HP_0000179) (Thick lower lip vermilion))) 39.81%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 39.03%
- [HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 39.03%


